High fat diet induced hepatocyte exosomes-promoted hepatic inflammation and tumorigenesis

高脂饮食诱导肝细胞外泌体促进肝脏炎症和肿瘤发生

基本信息

  • 批准号:
    8813882
  • 负责人:
  • 金额:
    $ 18.47万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2016
  • 资助国家:
    美国
  • 起止时间:
    2016-06-10 至 2021-03-31
  • 项目状态:
    已结题

项目摘要

ABSTRACT The overall goal of this proposal is to study the role of hepatocyte exosomes in high fat diet mediated promotion of liver cancer development. Further, we will determine whether using novel edible fruit exosomes as a delivery vehicle for targetable delivery of an anti-inflammatory agent to tumor cells for treatment of liver cancer. Our preliminary data has indicated that hepatocyte exosomes are present in the peripheral blood of obese mice and obese individuals and the hepatocyte exosomes from mice fed a high-fat diet (HFD- exosomes) promote inflammatory responses and the growth of liver cancer in mouse model. These data implicate the production of hepatocyte exosomes in the inflammatory responses associated with liver cancer. Our preliminary data indicate that the HFD-exosomes carry high levels of sumoylated CSN5 (sumo-CSN5) and that the delivery of the sumo-CSN5 to immature myeloid promotes the degradation of Jak3, a process that is essential for differentiation of the myeloid cells. This pinpointed the production of the sumo-CSN5 as a critical pathogenic step in exosomes mediated Induction of inflammation cytokines. In hepatocyte cells, ErK1/2 kinase is activated by a soluble factor(s) from the supernatant of liver extracts of high fat-fed mice and causes the disassociation of Senp1 which acts as a suppressor of sumoylation of CSN5, thereby promoting the production of sumo-CSN5. This process is inhibited by curcumin, which is known to inhibit ErK1/2 activation. Therefore, we hypothesize that a high-fat diet promotes the production of exosomes with high levels of sumo-CSN5 by hepatocyte cells; that these exosomes are taken up by immature myeloid cells, resulting in sumo-CSN5- mediated immunosuppression by enhancing degradation of Jak3, and thus the promotion of tumor growth. We further hypothesize that curcumin treatment leads to the inhibition of processing of sumoylation of CSN5 in the hepatocyte cells from mice fed a high-fat diet by inhibition of ErK1/2. These hypotheses will be tested in vitro and in vivo to determine whether: (1) Sumoylated CSN5 in high-fat hepatocyte exosomes is essential for accumulation of activated iMCs and promotion of liver tumor progression; (2) The ErK1/2 signaling pathway determines the balance of desumoylation vs. sumoylation of CSN5 in hepatocyte cells and is promoted by a high-fat diet; and (3) the high-fat diet-induced hepatocyte exosome-mediated promotion of liver tumor growth is reversible by using novel edible fruit exosomes as a delivery vehicle for targetable delivery of an anti- inflammatory agent to inflammatory cells for treatment of cancer. Clinical Relevance. The data generated should identify a novel mechanism that links a high-fat diet to inflammatory and immunosuppressive responses associated with tumor development and thereby identify molecular targets for chemotherapy or chemoprevention. Demonstration of the safety of fruit exosomes-based delivery of curcumin and its targeting to inflammatory cells would be a significant step forward in the treatment of this debilitating disease.
摘要 这项提案的总体目标是研究肝细胞外泌体在高脂饮食介导的肝细胞凋亡中的作用。 促进肝癌发展。此外,我们将确定是否使用新的可食用水果外泌体 作为用于将抗炎剂靶向递送至肿瘤细胞以治疗肝脏疾病的递送载体 癌我们的初步数据表明,肝细胞外泌体存在于外周血中, 肥胖小鼠和肥胖个体以及来自喂食高脂肪饮食(HFD-1)的小鼠的肝细胞外泌体。 外泌体)促进小鼠模型中的炎症反应和肝癌的生长。这些数据 肝细胞外泌体的产生与肝癌相关的炎症反应有关。 我们的初步数据表明,HFD-外泌体携带高水平的sumoylated CSN 5(sumo-CSN 5)和高水平的sumo-CSN 5。 向未成熟的骨髓细胞递送sumo-CSN 5促进了Jak 3的降解,这一过程 对骨髓细胞的分化至关重要。这指出,生产的sumo-csn 5作为一个关键的 外来体介导的炎症细胞因子诱导中的致病步骤。在肝细胞中,ErK 1/2激酶 被来自高脂喂养小鼠肝提取物上清液的可溶性因子激活, 作为CSN 5类小泛素化抑制剂的Senp 1的解离,从而促进CSN 5的产生 Sumo-CSN5这一过程被姜黄素抑制,姜黄素已知抑制ErK 1/2活化。因此,我们认为, 我们假设高脂饮食通过以下方式促进具有高水平sumo-CSN 5的外泌体的产生: 肝细胞;这些外来体被未成熟的骨髓细胞摄取,导致sumo-CSN 5- 通过增强Jak 3的降解介导免疫抑制,从而促进肿瘤生长。我们 进一步假设姜黄素治疗导致抑制CSN 5的类小泛素化的加工, 通过抑制ErK 1/2,从喂食高脂饮食的小鼠获得肝细胞。这些假设将在体外进行检验 (1)高脂肪肝细胞外泌体中的类小泛素化CSN 5对于肝细胞外泌体的形成是否是必需的。 激活的iMCs的积累和促进肝脏肿瘤进展;(2)ErK 1/2信号通路 决定了肝细胞中CSN 5的去小泛素化与小泛素化的平衡, 高脂饮食;和(3)高脂饮食诱导的肝细胞外来体介导的肝肿瘤生长促进, 通过使用新的可食用水果外来体作为用于靶向递送抗肿瘤药物的递送载体, 用于治疗癌症的炎性试剂与炎性细胞的结合。临床相关性。生成的数据 应该确定一种新的机制,将高脂肪饮食与炎症和免疫抑制反应联系起来, 与肿瘤发展相关,从而确定化疗的分子靶点, 化学预防证明基于水果外泌体的姜黄素递送的安全性及其靶向 将是治疗这种使人衰弱的疾病的重要一步。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Zhong-Bin Deng其他文献

Zhong-Bin Deng的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Zhong-Bin Deng', 18)}}的其他基金

The role of neutral ceramidase in intestinal fucosylation and liver steatosis and inflammation
中性神经酰胺酶在肠道岩藻糖基化以及肝脏脂肪变性和炎症中的作用
  • 批准号:
    10632084
  • 财政年份:
    2022
  • 资助金额:
    $ 18.47万
  • 项目类别:
The role of neutral ceramidase in intestinal fucosylation and liver steatosis and inflammation
中性神经酰胺酶在肠道岩藻糖基化以及肝脏脂肪变性和炎症中的作用
  • 批准号:
    10517197
  • 财政年份:
    2022
  • 资助金额:
    $ 18.47万
  • 项目类别:
Defining the role of S1p and myeloid cells during enterotoxigenic B. fragilis infection
定义 S1p 和骨髓细胞在产肠毒素脆弱拟杆菌感染过程中的作用
  • 批准号:
    10493352
  • 财政年份:
    2021
  • 资助金额:
    $ 18.47万
  • 项目类别:
Defining the role of S1p and myeloid cells during enterotoxigenic B. fragilis infection
定义 S1p 和骨髓细胞在产肠毒素脆弱拟杆菌感染过程中的作用
  • 批准号:
    10369893
  • 财政年份:
    2021
  • 资助金额:
    $ 18.47万
  • 项目类别:
Gut extracellular vesicles promote alcohol-induced liver injury via TLR4-regulated miRNAs
肠道细胞外囊泡通过 TLR4 调节的 miRNA 促进酒精引起的肝损伤
  • 批准号:
    9753076
  • 财政年份:
    2018
  • 资助金额:
    $ 18.47万
  • 项目类别:
Gut extracellular vesicles promote alcohol-induced liver injury via TLR4-regulated miRNAs
肠道细胞外囊泡通过 TLR4 调节的 miRNA 促进酒精引起的肝损伤
  • 批准号:
    9804746
  • 财政年份:
    2018
  • 资助金额:
    $ 18.47万
  • 项目类别:
CSN8 regulation of S1P-enriched extracellular vesicles to modulate NAFLD by gut-liver axis
CSN8 调节富含 S1P 的细胞外囊泡通过肠肝轴调节 NAFLD
  • 批准号:
    10392896
  • 财政年份:
    2018
  • 资助金额:
    $ 18.47万
  • 项目类别:
CSN8 regulation of S1P-enriched extracellular vesicles to modulate NAFLD by gut-liver axis
CSN8 调节富含 S1P 的细胞外囊泡通过肠肝轴调节 NAFLD
  • 批准号:
    9913998
  • 财政年份:
    2018
  • 资助金额:
    $ 18.47万
  • 项目类别:
Intestinal epithelial cells-derived exosomal miRNAs regulate liver inflammation in obesity
肠上皮细胞来源的外泌体 miRNA 调节肥胖中的肝脏炎症
  • 批准号:
    9385034
  • 财政年份:
    2017
  • 资助金额:
    $ 18.47万
  • 项目类别:
High fat diet induced hepatocyte exosomes-promoted hepatic inflammation and tumorigenesis
高脂饮食诱导肝细胞外泌体促进肝脏炎症和肿瘤发生
  • 批准号:
    9293342
  • 财政年份:
  • 资助金额:
    $ 18.47万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 18.47万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 18.47万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 18.47万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 18.47万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 18.47万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 18.47万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 18.47万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 18.47万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 18.47万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 18.47万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了